Functional analysis of p.Ala253_Leu254insAsn mutation in PLS3 responsible for X-linked osteoporosis

Clin Genet. 2018 Jan;93(1):178-181. doi: 10.1111/cge.13081. Epub 2017 Oct 29.

Abstract

Mutations in Plastin-3 (PLS3) have been identified as a cause of X-linked osteoporosis. To reveal the molecular mechanism of PLS3 on osteoporosis, we characterized the p.Ala253_Leu254insAsn mutation in PLS3. We first identified Lymphocyte cytosolic protein 1 (LCP1) as a binding partner of PLS3 and the mutation disrupted the interaction between them. We then confirmed the roles of PLS3 and LCP1 in the regulation of intracellular Ca2+ , which was weakened by the mutant PLS3. Moreover, the interaction between PLS3 and LCP1 was enhanced under a low concentration of extracellular Ca2+ . However, the mutation in PLS3 weakened the responsiveness. The reduced regulation on Ca2+ caused by p.Ala253_Leu254insAsn may be the possible molecular mechanism of osteoporosis.

Keywords: LCP1; PLS3; intracellular calcium; osteoporosis; p.Ala253_Leu254insAsn.

MeSH terms

  • Calcium / metabolism
  • Calcium / pharmacology
  • Cell Line
  • Genetic Diseases, X-Linked / genetics
  • Genetic Predisposition to Disease / genetics*
  • HEK293 Cells
  • Humans
  • Membrane Glycoproteins / genetics*
  • Membrane Glycoproteins / metabolism
  • Microfilament Proteins / genetics*
  • Microfilament Proteins / metabolism
  • Mutation*
  • Osteoporosis / genetics*
  • Protein Binding / drug effects

Substances

  • LCP1 protein, human
  • Membrane Glycoproteins
  • Microfilament Proteins
  • plastin
  • Calcium